CONCLUSION The thin polyacrylamide fibrin plate assay was suitable for detecting fibrinolysis activity in vitro.
结论本方法是一种值得推广的溶栓活性体外检测方法。
The fibrinolysis activity of the fermented fluid was determined and analyzed by the thrombolysis experiment in vitro.
再对复筛得到的菌株进行摇瓶培养，用纤维蛋白平板法测定并比较不同菌株发酵液的纤溶活性。
Objective To investigate the changes of plasm fibrinolysis activity in Mongolian patients with coronary heart disease(CHD).
目的研究蒙古族冠心病（CHD）发病与血浆纤溶活性变化的关系。
AIM: to construct engineered E. coli strains which can express nattokinase with fibrinolysis activity using gene engineering technology.
目的：利用基因工程技术，构建表达具溶栓活性的纳豆激酶的大肠杆菌工程菌。
OBJECTIVE To establish a method for detecting and analyzing fibrinolysis activity in vitro and high throughput screening fibrinolysis drugs.
目的建立一种用于体外溶栓活性精确定量分析和高通量溶栓药物筛选鉴定的方法。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Objective To study the activity changes of coagulation and fibrinolysis in stroke prone renovascular hypertensive rats (RHRSP).
目的动态观察易卒中型肾血管性高血压大鼠(RHRSP)血液中凝血系统和纤溶系统的活性改变。
With the increase of PAI-1, the activity of fibrinolysis was reduce at the aged and then the risk of development of cardiovascular and celebral vascular diseases would significantly increase.
PAI-1水平与年龄显著相关，使老年人机体的纤溶活性降低，糖尿病大血管病并发症发生的机会增加。
With the increase of PAI-1, the activity of fibrinolysis was reduce at the aged and then the risk of development of cardiovascular and celebral vascular diseases would significantly increase.
PAI-1水平与年龄显著相关，使老年人机体的纤溶活性降低，糖尿病大血管病并发症发生的机会增加。
应用推荐